Essayer OR - Gratuit
Role of nitric oxide in controlling genetic regulators to maintain cellular health
Express Pharma
|June 2025
Prof Syamantak Majumder, Prof Sandeep Sundriyal, and Prof Shibasish Chowdhury, researchers at BITS Pilani, reveal how nitric oxide regulates the EZH2 protein through S-nitrosylation in blood vessel cells. This discovery sheds light on vascular stability and opens new avenues for treating conditions like heart attacks and strokes
-
When you think of gases involved in your health, oxygen probably tops the list. But there's another gas, nitric oxide, that quietly plays a crucial role in keeping your body running smoothly. Though it might sound like something from a chemistry lab, nitric oxide is made right inside your body. In fact, the discovery of this gaseous molecule led to the Nobel Prize in Physiology or Medicine in 1998 to Dr Robert F Furchgott, Dr Louis J Ignarro, and Dr Ferid Murad for their discoveries concerning nitric oxide as a signaling molecule in the cardiovascular system. However, we are still far from understanding the complex set of regulations this gaseous molecule governs, and Scientists are still uncovering how deeply it's involved in cellular health.
In our recent study published in Nature Communications (1), we explored how this tiny, simple molecule interacts with proteins inside endothelial cells, the cells that line your blood vessels. What we found opens a new window into how nitric oxide helps regulate key proteins that maintain the health and balance of your vascular system. At the heart of this discovery is a protein called EZH2, and a chemical process called S-nitrosylation.
The central player: Nitric oxideNitric oxide is a short-lived gas that your body naturally produces. It plays an essential role in many bodily functions—from helping your blood vessels relax and widen, to controlling how cells communicate, move, and even defend themselves.
Cette histoire est tirée de l'édition June 2025 de Express Pharma.
Abonnez-vous à Magzter GOLD pour accéder à des milliers d'histoires premium sélectionnées et à plus de 9 000 magazines et journaux.
Déjà abonné ? Se connecter
PLUS D'HISTOIRES DE Express Pharma
Express Pharma
Standardisation vs customisation in single-use systems for bioprocessing: What do biopharma companies need?
Priyabrata Pattnaik, CEO, Ami Polymer highlights the balance between standardisation and customisation in single - use systems in biopharma manufacturing
5 mins
May 2026
Express Pharma
Ensuring Pharma compliance with testo data measurement technology
Due to the crucial necessity and its direct impact on human health and welfare, Pharma is probably the most important and critical sector among others.
3 mins
May 2026
Express Pharma
China+1 moment for pharma: How India can convert opportunity into long-term contracts
Manish Jain, Director, Naprod Life Sciences explains how India must move beyond cost advantage to lead with reliability, quality, and transparency to reshape global pharma supply chains and position itself as a trusted, long-term partner
3 mins
May 2026
Express Pharma
Beyond scale: Rethinking new frontiers in building excellence
At the Injectable Innovations Conclave 2026, hosted by Express Pharma, industry leaders examined the trends, technologies and strategies shaping the next phase of injectable growth, reports
10 mins
May 2026
Express Pharma
Waters receives CE mark for BD BACTEC FXI Culture System under EU IVDR
Next-generation blood culture system records ~3-hour faster detection time and introduces automated blood volume measurement
2 mins
May 2026
Express Pharma
JNPC: Carrying forward a 20-year old legacy
Billed as India's first bulk drug, chemicals and allied manufacturing parks and one of the most successful public-private partnerships (PPP) in the pharma sector, the Jawaharlal Nehru Pharma City (JNPC), also known as Visakha Pharma City, was set up in February 2005 as a PPP initiative by the Govt of Andhra Pradesh (GoAP) through its nodal agency Andhra Pradesh Industrial Infrastructure Corporation (APIIC) with the Ramky Group on a Build-Own-Operate (BOO) basis for 20 years.
3 mins
May 2026
Express Pharma
Romaco's sustainable blister packaging line at interpack
At this year's interpack, the Romaco Group will present its sustainable Unity 600 high-speed blister packaging line, featuring – for the first time – the PF 75 stretch bander.
6 mins
May 2026
Express Pharma
Even drug-resistant cancer targets can be tackled with the right design strategy
Dr Bajarang Kumbhar, Assistant Professor, Sunandan Divatia School of Science, NMIMS Mumbai, explains how Al-driven computational biology is reshaping CAR-T therapy and highlights how these approaches help cut drug discovery timelines and improve targeted, personalised cancer treatment, in an interaction with Kalyani Sharma
7 mins
May 2026
Express Pharma
Navigating legal and regulatory landscape of GLP-1 drugs in India
GLP-1 drugs are drawing sharp regulatory and legal scrutiny, especially with generics entering post-patent expiry. They emphasise that navigating IP, compliance, and marketing rules is now critical for stakeholders
5 mins
May 2026
Express Pharma
From back office to brain trust: How life sciences GCCs are redefining leadership hiring in India
Sai Gandhi, Partner, Positive Moves points out that life sciences GCCs in India are moving from support roles to driving core innovation and global strategy. In turn, leadership hiring is shifting toward cross-functional, globally savvy leaders who can deliver enterprise-wide impact
4 mins
May 2026
Listen
Translate
Change font size
